Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit

Abstract

Respiratory viral infections are major causes of morbidity and mortality in children with SCID and other primary immunodeficiencies who require BMT. Twenty-two of 73 (30%) such children were admitted with respiratory viral infections, of whom 13/22 (59%) died. All viruses were detected in nasopharyngeal aspirate (NPA). Virus was only found in BAL in those with LRTI. Eleven of 22 (50%) had paramyxovirus infections, all with severe viral pneumonitis which worsened post BMT. Five of 11 (45.5%) survived overall. All 11 received aerosolised ribavirin; five of 11 received additional inhaled immunoglobulin and corticosteroid. Three of 5 (60%) survived compared with two of six (33.3%) not thus treated. Three of 22 (13.6%) had adenoviruses; one died of disseminated disease, including pneumonia despite intravenous ribavirin. Eleven patients had rhinovirus detected; nine of 11 (82%) were asymptomatic or coryzal and survived. Two patients with additional severe lung pathologies had LRT rhinovirus and died. All patients received intravenous immunoglobulin. No treatments resulted in viral clearance without successful T cell engraftment. Respiratory viruses, particularly paramyxoviruses and adenoviruses are common, significant pathogens in these patients, significantly worsening outcome of BMT. NPA is an ideal specimen for diagnosis and monitoring of infection. Aggressive treatments may reduce viral replication and damage. Nebulised immunoglobulin and corticosteroid in LRTI may improve respiratory function and outcome. Bone Marrow Transplantation (2000) 26, 1097–1102.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fischer A, Landais P, Friedrich W et al. European experience of bone marrow transplantation for severe combined immunodeficiency Lancet 1990 336: 850–854

    Article  CAS  Google Scholar 

  2. Crooks B, Cant A, Abinun M et al. Combination therapy for post-bone marrow transplant pneumonitis. In: 2nd Annual Spring meeting of the Royal College of Paediatrics and Child Health 1998 York, UK 1998 p 94

  3. Rosen F, Wedgewood R, Eibl M et al. Primary immunodeficiency diseases: report of a WHO Scientific Group Clin Exp Immunol 1998 112: (Suppl. 1) 1–28

    Article  Google Scholar 

  4. Gardener P, McQuillin J . Rapid Virus Diagnosis: Application of Immunofluorescence Butterworth: London 1974

    Google Scholar 

  5. Prince G, Porter D . Treatment of parainfluenza type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid J Infect Dis 1996 173: 598–608

    Article  CAS  Google Scholar 

  6. Rimensberger P, Schaad U . Clinical experience with aerosolised immunoglobulin treatment of respiratory syncytial virus infection in infants Pediatr Infect Dis J 1994 13: 328–330

    Article  CAS  Google Scholar 

  7. Taylor C, Osman H, Turner A et al. Parainfluenza virus and respiratory syncytial virus infection in infants undergoing bone marrow transplantation for severe combined immunodeficiency Commun Dis Public Health 1998 1: 202–203

    CAS  PubMed  Google Scholar 

  8. Berrington J, Flood T, Abinun M et al. Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency Arch Dis Child 2000 82: 144–147

    Article  CAS  Google Scholar 

  9. Krilov L, Pierik L, Keller E et al. The association of rhinoviruses with lower respiratory tract disease in hospitalized patients J Med Virol 1986 19: 345–352

    Article  CAS  Google Scholar 

  10. Hierholtzer J . Adenoviruses in the immunocompromised host (review) Clin Microbiol Rev 1992 5: 262–274

    Article  Google Scholar 

  11. McCarthy A, Bergin M, Silva LD, Stevens M . Intravenous ribavirin therapy for disseminated adenovirus infection Pediatr Infect Dis J 1995 14: 1003–1004

    Article  CAS  Google Scholar 

  12. Wulffraat N, Geelen S, Dijken Pv et al. Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin Transplantation 1995 59: 927

    Article  CAS  Google Scholar 

  13. Groothuis J, Simoes E, Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children New Engl J Med 1993 329: 1524–1530

    Article  CAS  Google Scholar 

  14. DeVincenzo J, Leombruno D, Soiffer R, Siber G . Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation Bone Marrow Transplant 1996 17: 1051–1056

    CAS  Google Scholar 

  15. Harrington R, Hooton T, Hackman R et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center J Infect Dis 1992 165: 987–993

    Article  CAS  Google Scholar 

  16. McColl M, Corser R, Bremer J, Chopra R . Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin Bone Marrow Transplant 1998 21: 423–425

    Article  CAS  Google Scholar 

  17. Ljungman P . Respiratory virus infections in bone marrow transplant recipients: the European perspective Am J Med 1997 102: 44–47

    Article  CAS  Google Scholar 

  18. Wendt C, Weisdorf D, Jordan C et al. Parainfluenza virus respiratory infection after bone marrow transplantation New Engl J Med 1992 326: 921–926

    Article  CAS  Google Scholar 

  19. Hemming V, Prince G, London W et al. Topically administered immunoglobulin reduces respiratory syncytial virus shedding in owl monkeys Antimicrob Agents Chemother 1988 32: 1269–1270

    Article  CAS  Google Scholar 

  20. Piazza F, Johnson S, Ottolini M et al. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small particle aerosol generator J Infect Dis 1992 166: 1422–1424

    Article  CAS  Google Scholar 

  21. Ottolini M, Hemming V, Piazza F et al. Topical immunoglobulin is an effective therapy for P13 in a cotton rat model J Infect Dis 1995 172: 243–245

    Article  CAS  Google Scholar 

  22. Crooks B, Taylor C, Turner A et al. Clinical experience of respiratory viral infections in children undergoing bone marrow transplantation for primary immunodeficiencies Bone Marrow Transplant 1999 23: (Suppl. 1) S113

    Google Scholar 

Download references

Author information

Authors and Affiliations

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crooks, B., Taylor, C., Turner, A. et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplant 26, 1097–1102 (2000). https://doi.org/10.1038/sj.bmt.1702656

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702656

Keywords

This article is cited by

Search

Quick links